4GOODIN D S,FROHAMA E M,GAMANY G P,et al.Disease modifying therapies in multiple sclerosis subcomittee of the American Academy of Neurology and MS council for clinical practice guidelines[J].Neurology,2002,58(2):1692-1178. 被引量：1
5TINDALL R.A closer look at plasmapheresis in multiple sclerosis:the cons[J].Neurology,1988,38 (7Suppl 2):53-56. 被引量：1
6KAYNAR L,ALTUNTAS F,AYDOGDU Ⅰ,et al.Therapeutic plasma exchange in patients with neurologlc diseases:retrospective multicenter study[J].Transfus Apher Sci,2008,38(2):109-115. 被引量：1
7MEDENICA R D,MUKERJEE S,ALONSO K,et al.Plasmapheresis combined with interferon:an effective therapy for multiple sclerosis[J].Clin Apher,1994,9(4):222-227. 被引量：1
9Goodin DS,Frohama EM,Gamany GP,et al.Disease modifying therapies in multiple sclerosis subcomittee of the American Academy of Neurology and MS council for clinical practice guidelines[J].Neurology,2002,58(2):1178-1692. 被引量：1
10Tindall R.A closer look at plasma pheresis in multiple sclerosis:the cons[J].Neurology,1998,38(7Suppl2):53-56. 被引量：1
